18 results
6-K
EX-99.1
LEGN
Legend Biotech Corporation
13 May 24
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
7:01am
growth strategy for good corporate citizenship
* In December 2017, Legend Biotech entered into an exclusive worldwide collaboration and license
F-3ASR
LEGN
Legend Biotech Corporation
19 Mar 24
Automatic shelf registration (foreign)
7:57am
signature and (ii) such other information, including without limitation, information as to citizenship, residence, exchange control approval
F-3ASR
LEGN
Legend Biotech Corporation
26 May 23
Automatic shelf registration (foreign)
9:01am
of any signatory and genuineness of any signature and (ii) such other information, including without limitation, information as to citizenship
424B5
LEGN
Legend Biotech Corporation
8 May 23
Prospectus supplement for primary offering
8:45am
limitation, information as to citizenship, residence, exchange control approval, beneficial or other ownership of, or interest in, any securities, compliance
424B5
u1fn3g71jbdlff5
27 Jul 22
Prospectus supplement for primary offering
4:32pm
424B5
dogsk7s6kvg1
25 Jul 22
Prospectus supplement for primary offering
4:29pm
424B5
6jlcho
17 Dec 21
Prospectus supplement for primary offering
4:16pm
424B5
jwaar pcftw
14 Dec 21
Prospectus supplement for primary offering
4:40pm
424B3
288zz87jyeq 7e4jgv
14 Jul 21
Prospectus supplement
4:06pm
F-3
iok12kjf3u9b5cwg05a
2 Jul 21
Shelf registration (foreign)
7:36am
F-3ASR
to1hhy1vw2xa2f
1 Jul 21
Automatic shelf registration (foreign)
4:32pm
20-F
EX-2.5
urpdgr
2 Apr 21
Annual report (foreign)
8:10am
S-8
EX-4.3
8vp12 bj533ooad
26 Jun 20
Registration of securities for employees
4:11pm
F-1/A
EX-4.2
66abpy3gy5bpc2bo
29 May 20
Registration statement (foreign) (amended)
8:32am
F-6
EX-99
jijcvl
21 May 20
Registration for ADRs (foreign)
5:12pm
- Prev
- 1
- Next